List view / Grid view
25 January 2016 | By Victoria White
The Apollo Therapeutics Fund will support the translation of ground-breaking academic science into innovative new medicines for a broad range of diseases...
22 December 2015 | By Victoria White
The funding is awarded in the context of the Neuratect CRACK IT Challenge to support development of better predictive, high-throughput, animal-free models for neurotoxicity of medicines and chemicals...
21 October 2015 | By Kate Douetil
This innovative new global investment fund has gained support from a wide variety of investors, including the UK Government’s Department of Health (DoH), Alzheimer’s Research UK and world-leading major pharmaceutical companies Biogen, GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer and Takeda...
6 August 2015 | By Synthesis and Solid State Pharmaceutical Centre (SSPC)
Read how the Synthesis and Solid State Pharmaceutical Centre (SSPC) is positioning Ireland as a global hub for advanced pharmaceutical manufacturing...
15 July 2015 | By Victoria White
GSK and MRC are to collaborate on a unique open innovation research initiative aiming to improve scientists’ understanding of inflammatory diseases...
14 July 2015 | By Victoria White
The Francis Crick Institute and GSK are to partner up to explore new avenues of medical research and drug discovery across a broad range of diseases...
30 June 2015 | By Cisbio Bioassays & Trevena, Inc.
TRV027 is a biased ligand; the in vitro profile and its translation into in vivo pharmacology is discussed during this webinar.
17 June 2015 | By Victoria White
GSK is making a substantial investment to launch the Altius Institute for Biomedical Sciences (Altius), an independent, non-profit research institute...
12 June 2015 | By Victoria White
Tessella has joined the the Pistoia Alliance- an alliance of organisations that work together to lower barriers to innovation in Life Science R&D...
3 June 2015 | By Victoria White
Auspherix has raised £6 million in a Series A venture financing and is establishing operations on the Stevenage Bioscience Catalyst site...
29 May 2015 | By Victoria White
Padlock Therapeutics has entered into an agreement to license intellectual property and a collection of assets targeted at PADs from GSK...
11 May 2015 | By Victoria White
UNC-Chapel Hill and GSK have announced the creation of a dedicated HIV Cure centre and a new company that will focus on discovering a cure for HIV/AIDS...
8 April 2015 | By SMi Group
SMi Group are thrilled to present the 3rd annual European event: Lyophilisation Europe, taking place on 29th & 30th June 2015, in Central London...
8 January 2015 | By Oxford Global Conferences
Oxford Global Conferences were proud to present the Drug Discovery USA Congress this October in Boston, USA...
3 October 2014 | By OBN
OBN revealed last night the winners of its Annual Awards celebrating the best of UK life sciences – the innovators, fundraisers and dealmakers who underline the pre-eminence of the UK sector in the global marketplace...
